When levels are high, doctors tend to be less aggressive with statins, even though HDL shouldn’t be used to guide treatment.

Juan Granada and Pierre Elias discuss how AI is an essential tool for improving screening access and increasing early ...

Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.

A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.

Yet the disparities by sex, race/ethnicity, and location pale in comparison to a striking overall lack of adoption.

The controversial taNRP protocol shortens ischemic time for donations after circulatory death and improves outcomes.

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Investigators for both studies said ongoing analyses will help put the divergent management strategies into better context.

Despite the positive results, there are open questions about LBB pacing, including long-term lead performance. RCTs are ...

Our coverage of ACC 2025 in Chicago dominated our most-read stories, but other news on novel therapies made the list, too.

The choice between ICD types still should be based on each individual patient’s risk factors, Kenneth Ellenbogen says.

The novel aldosterone inhibitor works, but longer-term safety data are needed before the drug might be approved.